期刊文献+

凋亡在缺血性急性肾功能衰竭中研究进展

原文传递
导出
摘要 凋亡在缺血性急性肾功能衰竭的发病机制中起重要作用,研究发现缺血性急性肾功能衰竭中有多种机制影响凋亡的发生。
出处 《国际泌尿系统杂志》 2007年第4期503-506,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献23

  • 1Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemia - reperfusion injury in rat kidney. FASEB Journal,2003,17(12) :1754 - 1755.
  • 2Vesey DA, Cheung C, Pat B ,et al. Erythropoietin protects against ischaemic acute renal injury. Nephrology Dialysis Transplantation, 2004,19(2) :348-355.
  • 3Spandou E,Tsouehnikas I,Karkavelas G,et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrology Dialysis Transplantation, 2006, 21 ( 2 ) : 330 - 336.
  • 4Kurmasheva RT, Houghton PJ. IGF- I mediated survival pathways in normal and malignant cells. Biochimica et Biophysica Acta, 2006, 1766(1) :1 -22.
  • 5Johnson DW, Pat B, Vesey DA, et al. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney International ,2006,69( 10 ) : 1806 - 1813.
  • 6Franquesa M, Alperovich G, Herrero - Fresneda I, et al. Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Therapy,2005,12(21) : 1551 - 1558.
  • 7Mizuno S, Nakamura T. Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. American Journal of Pathology,2005,166 (6) : 1895 - 1905.
  • 8Hirschberg R, Ding H. Mechanisms of insulin - like growth factor - I -induced accelerated recovery in experimental ischemic acute renal failure. Mineral & Electrolyte Metabolism, 1998,24(4 ) :211 - 219.
  • 9Medina A, Fernandez - Fuente M, Carbajo - Perez E, et al. Insulin - like growth factor I administration in young rats with acute renal failure. Pediatric Nephrology,2002,17 ( 12 ) : 1005 - 1012.
  • 10Faubel S, Edelstein CL. Caspases as drug targets in ischemic organ injury. Current Drug Targets - Immune Endocrine & Metabolic Disorders, 2005,5 ( 3 ) : 269 - 287.

二级参考文献16

  • 1Yuan J;Yankner BA.Apoptosis in the nervous system[J],2000(6805).
  • 2Gobe G;Willgoss D;Hogg N;Schoch E,Endre Z.Cell survival or death in renal tubularepithelium after ischemia-reperfusion injury[J],1999(04).
  • 3Meier P;Finch A;Evan G.Apoptosis in development[J],2000(6805).
  • 4Rathmell JC;Thompson CB.Pathways of apoptosis in lymphocyte development,homeostasis,and disease[J],2002(Suppl).
  • 5Ameisen JC.On the origin,evolution and nature of programmed cell death:a timeline of four billion years[J],2002(04).
  • 6Kiechle FL;Zhang X.The postgenomic era.Implications for the clinical laboratory[J],2002.
  • 7Ramos F;Fuertes Nunez M;Suarez Vilela D;Fernandez Lopez A.What does apoptosis have to do with clinical features of myelodysplastic syndrome?,2002(04).
  • 8Markstrom E;Svensson ECh;Shao R;Svanberg B,Billig H.Survival factors regulating ovarian apoptosis-dependence of follicule differentiation[J],2002(01).
  • 9Mullauer L;Gruber P;Sebinger D;Buch J,Wohlfart S,Chott A.Mutations in apoptosis genes:A pathogenetic factor for human disease,2001.
  • 10Hanlon MG;Gacis ML;Kakakios AM;Kilham H.Investigation of suspected deficient Fas-mediated apoptosis in a father and son[J],2001(03).

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部